|
SNX2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.71110000904918E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.18629999951759E-09 |
| Normal-vs-Stage2 |
4.40820000000564E-05 |
| Normal-vs-Stage3 |
1.297190E-03 |
| Normal-vs-Stage4 |
5.924100E-02 |
| Stage1-vs-Stage2 |
5.057800E-01 |
| Stage1-vs-Stage3 |
6.645600E-01 |
| Stage1-vs-Stage4 |
4.480600E-01 |
| Stage2-vs-Stage3 |
9.367600E-01 |
| Stage2-vs-Stage4 |
6.715400E-01 |
| Stage3-vs-Stage4 |
7.114600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35339994766781E-09 |
| Normal-vs-AfricanAmerican |
9.62629999999853E-05 |
| Normal-vs-Asian |
7.025400E-01 |
| Caucasian-vs-AfricanAmerican |
1.556640E-01 |
| Caucasian-vs-Asian |
4.430000E-01 |
| AfricanAmerican-vs-Asian |
6.082200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.53989998530335E-09 |
| Normal-vs-Female |
2.043600E-04 |
| Male-vs-Female |
1.045970E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.397510E-04 |
| Normal-vs-Extreme_Weight |
9.69669899930636E-11 |
| Normal-vs-Obese |
3.03550000024799E-07 |
| Normal-vs-Extreme_Obese |
1.149510E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.412200E-01 |
| Normal_Weight-vs-Obese |
9.121200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.378000E-01 |
| Extreme_Weight-vs-Obese |
1.910230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.274800E-01 |
| Obese-vs-Extreme_Obese |
6.849800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.220700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.91529999971074E-07 |
| Normal-vs-Age(61-80Yrs) |
9.76829950261049E-10 |
| Normal-vs-Age(81-100Yrs) |
3.99229999999973E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.758600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.528400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.159000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.152160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.665000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.982000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.28299601445769E-11 |
| Normal-VS-Type2 PRCC |
1.738300E-03 |
| Normal-VS-KIRP CIMP |
3.437200E-04 |
| Normal-VS-Unclassified PRCC |
1.973210E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.276000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.556000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.088000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.756600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.328200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.996200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.06919999995647E-06 |
| Normal-vs-N1 |
5.439800E-04 |
| Normal-vs-N2 |
7.624400E-02 |
| N0-vs-N1 |
5.299400E-01 |
| N0-vs-N2 |
7.039600E-01 |
| N1-vs-N2 |
9.289000E-01 |
|
|
